The abstract is read at the publisher; the summary is JClub's.
GLP1R R131Q is linked to preserved β-cell function and stronger GLP-1RA–stimulated insulin secretion, with homozygous carriers showing a 30% baseline reduction in disposition index.
- Why it matters: Genetic differences in GLP1R may shape both type 2 diabetes risk and how well patients respond to GLP-1 receptor agonists, but the functional basis is unclear.
- What they did: In a 20-year Korean community cohort (n = 6,373), disposition index trajectories from biennial 2-h 75-g oral glucose tolerance tests were analyzed, and GLP-1RA response was tested in a Korean T2D cohort (n = 177) plus clamp (n = 17), human islets (n = 21), and in vitro signaling assays.
- The result: In T2D, each allele is associated with an additional 0.53% or 5.8 mmol/mol HbA1c reduction after 6 months of GLP-1RA treatment (P = 5.8 × 10-4), and allele-dependent enhancement of GLP-1RA–stimulated insulin secretion was observed (P = 0.050; P = 0.037).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.